Today’s annual report state:
“The Company is now fully focused on achieving commercial transaction(s) for the Company’s portfolio of antiviral programs.”
MM has put $300k into the company by converting 2m of 15c options (expires 30 November 2018).
She could buy BIT at 4c after the results announcement just two weeks ago, but she converted November options at bout 4 time price.
Maybe she is subject to blackperiod, can’t buy at the moment, due to briefing to potential pharmaceutical partners?
MM will be presenting at Australia Biotech Invest & Partnering 2018 on 30 October:
Commercial transactions
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |